In addition, downregulation of CHCHD6 in the hippocampus of APP-based mouse models of AD mice promotes aberrant neuronal cholesterol accumulation, amyloidogenesis, synaptic loss, and neuroinflammation, with compensation for CHCHD6 loss mitigating this pathology. The gene discussed is CHCHD6; the disease is Alzheimer disease.